Word: hoechst
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...this week denied suggestions that a West German company contracted to support molecular biology research at MGH would take advantage of public funds to make money. Martin S. Bander, head of news and public affairs at MGH, took issue with Rep. Albert Gore Jr. (D-Tenn.), who said that Hoechst A. G., the company, "contemplated the opportunity to leverage public investment at the hospital to its own interest." Under an agreement reached last May, Hoechst will fund molecular biological research at MGH and receive the right to profit from it before other companies gain access to the findings...
...about possible conflicts between unbiased scientific investigation and corporate profits. Harvard again became a focal point of attention in this area this spring when two weeks after one of its teaching hospitals, the Massachusetts General Hospital, announced it had received a $60-million grant from the German chemical firm Hoechst, the Medical School announced that it had received a $6-million grant of its own from DuPont. Both of the grants will fund research in the controversial field of recombinant...
...grant of $23 million for research to be conducted under the guidance of two Medical School professors. The announcement surprised--and provoked--many scientists at Harvard and nationwide, and some of the same questions were raised which have since been brought up in relation to the DuPont and the Hoechst deals...
Sanders, who first came to the Medical School in 1958 as a research fellow in cardiology, presided over a successful $114 million fund drive at MGH and negotiated the recent $60-million agreement with the Hoechst Corporation of Germany, the world's largest pharmaceutical company, for research on DNA at the hospital...
Meanwhile, though, Mass General has declined to comply with a request from Congress to reveal the details of its agreement with Hoechst, a position that will no doubt continue to create distrust and may result in a formal subpoena, staffers on the Science and Technology Committee say. Harvard does not anticipate formal investigation of the Du Pont grant, but the same Congressional sources indicate that they will scrutinize the information available before deciding whether the public deserves to know more. "Unless we hear some good reason, there seems to be no benefit in this type of interference," Lamont-Havers says...